MitoMIND™ Helmet | Near Infrared Light Therapy for Brain Wellness

The MitoMIND™ Helmet uses 810nm near-infrared light — the most studied wavelength for transcranial photobiomodulation (tPBM). 810nm sits at a peak absorption window for cytochrome c oxidase (CCO), the terminal enzyme of the mitochondrial respiratory chain. It also falls within the tissue optical window, where near-infrared light penetrates biological tissue — including the skull — more effectively than shorter wavelengths. The brain's high metabolic demand makes mitochondrial stimulation particularly relevant for cognitive and neurological support, which is why 810nm has been the primary wavelength studied in clinical tPBM research.

The MitoMIND™ 1070nm intranasal attachment delivers near-infrared light via the nasal cavity, which sits in direct anatomical proximity to the brain and olfactory region. This provides a complementary delivery route to the transcranial helmet — the light travels through the nasal mucosa and the dense vascular network of the nasal passages, reaching brain tissue via a path that doesn't require penetration through the skull at all.

Why 1070nm specifically? Research has identified 1070nm as a second cytochrome c oxidase absorption peak, distinct from 810nm. Using both wavelengths via both delivery routes — transcranial (810nm) and intranasal (1070nm) — covers more photoreceptor activation pathways simultaneously. The helmet + intranasal bundle is the most comprehensive transcranial PBM configuration the MitoMIND™ system offers.

Transcranial photobiomodulation (tPBM) is the application of red or near-infrared light directly to the scalp and skull with the intent of delivering photonic energy to brain tissue. Regular red light therapy targets skin, muscle, and superficial tissue. tPBM is specifically aimed at the brain — the light must penetrate the scalp, skull bone, meninges, and cerebrospinal fluid to reach cortical neurons.

This requires near-infrared wavelengths (the MitoMIND™ uses 810nm) because shorter red wavelengths do not penetrate deeply enough to reach brain tissue in clinically meaningful quantities. The mechanism is the same — mitochondrial CCO activation — but the target organ and delivery engineering are entirely different from a panel or belt device.

The MitoMIND™ delivers light in pulsed mode at specific frequencies (Hz) that correspond to known human brainwave bands:

0 Hz (continuous) — no pulsing, used for the Recharge preset at full power.

2 Hz (Delta range) — associated with deep sleep states, used in the Sleep preset.

5 Hz (Theta range) — associated with meditative and hypnagogic states, used in the Meditate preset.

10 Hz (Alpha range) — associated with relaxed wakefulness and calm focus, used in the Relax preset.

16 Hz (Low Beta range) — associated with alert, engaged cognitive activity, used in the Concentrate preset.

40 Hz (Gamma range) — the most studied frequency in tPBM research, associated with high-level cognitive processing and attention, used in the Peak Focus preset. 40 Hz has been the subject of significant research for its potential role in supporting brain health.

Place the helmet on your head with the LED array oriented toward the scalp. Sessions run from 6–15 minutes depending on the preset selected. Simply select your program, press start, and the device will run the full session and shut off automatically.

For the intranasal unit (included in the Helmet + Intranasal bundle): insert the soft tip gently into one or both nostrils as directed. The intranasal unit can be used simultaneously with the helmet or as a standalone session.

Daily use is recommended for best results. Many users begin with the Recharge or Relax presets and progress to Peak Focus or Concentrate as they establish a routine.

If you are new to the MitoMIND™, we recommend starting with Recharge (0 Hz, 10 min) or Relax (10 Hz, 15 min) — both are well tolerated and provide a straightforward introduction to the device.

Sleep (2 Hz) is best used in the evening 30–60 minutes before bed.

Meditate (5 Hz) pairs well with breathwork or meditation practice.

Concentrate (16 Hz) and Peak Focus (40 Hz) are best used during or before periods of cognitive demand — work, study, or creative tasks. Peak Focus runs only 6 minutes at full power, making it easy to incorporate into a morning routine.

The custom settings allow you to further adjust time, pulse rate, and intensity beyond the presets if you want to explore more personalised configurations.

Yes — simultaneous use is the recommended approach when using the Helmet + Intranasal bundle. Using both at once delivers 810nm transcranially and 1070nm intranasally simultaneously, providing the broadest coverage across both delivery pathways and both cytochrome c oxidase absorption peaks. The control module manages both units from a single interface.

The MitoMIND™ and MitoBOOST™ are complementary but distinct products targeting different use cases:

MitoMIND™ — dedicated transcranial photobiomodulation helmet designed specifically for brain health, cognitive support, and neurological wellness. Uses 810nm via the helmet and 1070nm via the intranasal unit. Features six brainwave-frequency preset programs. The intranasal component is specifically 1070nm NIR for brain delivery.

MitoBOOST™ — modular multi-wavelength intranasal system designed for general wellness, immunity, sinus health, and circadian rhythm support. Offers red (650nm), blue (450nm), and NIR (1070nm) attachments plus MitoBUDS white-light earbuds. More of a travel wellness platform than a dedicated brain therapy device.

Serious users focused primarily on brain health and cognitive performance will find the MitoMIND™ the more purpose-built option. Users wanting a portable modular system for broader wellness use will find MitoBOOST™ the better fit.

Yes. The MitoMIND™ is an FDA Class II registered over-the-counter medical device. When used as directed it may provide temporary relief of minor muscle and joint stiffness, temporary increase in local blood circulation, support for healthy skin, and relaxation and recovery support. The device is not intended to diagnose, treat, cure, or prevent any medical condition.

Consult your physician before use if you have any of the following: active cancer (particularly any brain or head/neck malignancy), epilepsy or history of photosensitive seizures, implanted electronic devices in or near the head (pacemakers, cochlear implants, deep brain stimulators), are pregnant, are taking photosensitising medications, or have any active neurological condition under medical management.

Do not use directly over the eyes. The intranasal unit should not be used if you have active nasal infections, recent nasal surgery, or significant nasal obstruction. Children should use under adult supervision and with physician guidance.

The MitoMIND™ is a battery-powered DC device — it generates zero magnetic field from AC current and has zero flicker, as these are artifacts of AC power that do not apply to DC-powered devices. The helmet contains no Bluetooth or WiFi transmitters, so there are no RF (radio frequency) emissions. This makes it one of the cleanest EMF profiles of any wearable therapeutic device.

Both options include the MitoMIND™ 810nm transcranial helmet with the six preset programs and full custom settings capability.

The Helmet + Intranasal bundle adds the 1070nm near-infrared intranasal attachment, which provides a second and complementary delivery route for near-infrared light to the brain. 1070nm corresponds to a distinct cytochrome c oxidase absorption peak from 810nm, so the bundle covers both primary NIR photoreceptor activation pathways simultaneously via two anatomical delivery routes.

For users primarily interested in brain health and wanting the most comprehensive transcranial PBM experience the MitoMIND™ system offers, the bundle is the recommended choice. The intranasal unit cannot be purchased separately at a later date, so upgrading now is the more cost-effective path.

The MitoMIND™ comes with a 1-year manufacturer's warranty covering defects in materials and workmanship, plus a 60-day trial period. If you are not satisfied within 60 days of delivery, return it for a full refund. Contact our support team for any warranty claims and we will make it right.

As an FDA Class II registered medical device, the MitoMIND™ is generally eligible for purchase using HSA or FSA funds. We accept HSA/FSA cards directly at checkout via Truemed. Check with your plan administrator if you are unsure of your plan's specific eligibility rules. Truemed can assist with a Letter of Medical Necessity if your provider requires one.